SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $38,362,000 | -36.8% | 20,970,000 | -16.5% | 0.56% | -39.7% |
| Q3 2014 | $60,689,000 | +18.4% | 25,112,000 | +24.1% | 0.94% | +22.5% |
| Q2 2014 | $51,245,000 | +9.2% | 20,230,000 | -27.3% | 0.76% | +4.2% |
| Q1 2014 | $46,917,000 | -8.9% | 27,834,000 | -19.4% | 0.73% | +13.1% |
| Q4 2013 | $51,504,000 | +7.0% | 34,525,000 | -11.9% | 0.65% | +0.2% |
| Q3 2013 | $48,128,000 | -1.3% | 39,176,000 | -3.7% | 0.65% | -15.5% |
| Q2 2013 | $48,749,000 | – | 40,673,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $6,773,000 | 6.36% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $47,671,000 | 5.58% |
| Sage Capital Management, LLC | 1,660,000 | $4,009,000 | 3.83% |
| SYMPHONY ASSET MANAGEMENT LLC | 15,190,000 | $36,741,000 | 3.79% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,187,000 | $19,782,000 | 3.03% |
| CAMDEN ASSET MANAGEMENT L P /CA | 29,798,000 | $72,074,000 | 3.00% |
| Wellesley Asset Management | 15,250 | $36,969,000 | 2.29% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $20,801,000 | 2.12% |
| BNP PARIBAS FINANCIAL MARKETS | 7,500,000 | $1,814,100,096,000 | 1.58% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $75,372,000 | 1.57% |